Efficacy News and Research

RSS
Response to a third SARS-CoV-2 vaccine dose amongst immunocompromised

Response to a third SARS-CoV-2 vaccine dose amongst immunocompromised

Researchers assess the genetic features of T-cell immunity development to SARS-CoV-2 variants

Researchers assess the genetic features of T-cell immunity development to SARS-CoV-2 variants

First dose of COVID-19 vaccine to be offered to all young people aged 16 to 17 in England

First dose of COVID-19 vaccine to be offered to all young people aged 16 to 17 in England

Pfizer CEO to public: Just trust us on the covid booster

Pfizer CEO to public: Just trust us on the covid booster

Discovery of highly potent neutralizing monoclonal antibodies against SARS-CoV-2

Discovery of highly potent neutralizing monoclonal antibodies against SARS-CoV-2

How replication and recombination contribute to emergence of SARS-CoV-2 variants

How replication and recombination contribute to emergence of SARS-CoV-2 variants

Research debunks myth that COVID vaccination promotes mutations

Research debunks myth that COVID vaccination promotes mutations

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

Camelid nanobody anti-SARS-CoV-2 drug candidates

Camelid nanobody anti-SARS-CoV-2 drug candidates

Researchers determine the structure of receptor involved in type 2 diabetes and other pathologies

Researchers determine the structure of receptor involved in type 2 diabetes and other pathologies

Nanotechnology may help improve treatment for colorectal cancer and melanoma

Nanotechnology may help improve treatment for colorectal cancer and melanoma

New research offers hope to increase efficacy of immunotherapy for lung cancer

New research offers hope to increase efficacy of immunotherapy for lung cancer

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

COVID-19 vaccines offer better protection than natural immunity alone

COVID-19 vaccines offer better protection than natural immunity alone

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

Study shows efficacy of gamma irradiation of SARS-CoV-2 vaccine candidate in mouse model

Natural vs. vaccine-induced COVID-19 immunity

Natural vs. vaccine-induced COVID-19 immunity

Researchers create a computational model to evaluate drug delivery through inhalers

Researchers create a computational model to evaluate drug delivery through inhalers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.